Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Pharming Group N.V. - Filing #2154299

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—		—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	146,512,000 USD	—	—	—	148,297,000 USD	—	—	—	—	—
Current assets	—	—	316,342,000 USD	—	—	—	277,500,000 USD	—	—	—	—	—
Non-current liabilities	—	—	166,105,000 USD	—	—	—	161,461,000 USD	—	—	—	—	—
Current liabilities	—	—	77,968,000 USD	—	—	—	59,698,000 USD	—	—	—	—	—
Revenue	—	245,316,000 USD	—	—	—	—	—	—	—	205,622,000 USD	—	—
Profit (loss)	— USD	10,548,000 USD	—	10,548,000 USD	— USD	— USD	—	— USD	— USD	13,674,000 USD	— USD	13,674,000 USD
Other comprehensive income	— USD	7,103,000 USD	—	— USD	— USD	7,103,000 USD	—	— USD	11,054,000 USD	11,054,000 USD	— USD	— USD
Comprehensive income	— USD	3,445,000 USD	—	10,548,000 USD	— USD	7,103,000 USD	—	— USD	11,054,000 USD	2,620,000 USD	— USD	13,674,000 USD